| 摘要 |
A composition comprising (-) cisapride, or a pharmaceutically acceptable salt thereof, wherein the composition is for eliciting an antiemetic effect in a human by administering an amount thereof sufficient to alleviate nausea and vomiting whilst being insufficient to cause adverse side-effects associated with the administration of racemic cisapride, or while achieving a higher bioavailability than achieved with racemic cisapride; or the composition is for treating a condition caused by gastrointestinal motility dysfunction in a human by administering an amount thereof sufficient to alleviate said condition whilst being insufficient to cause adverse side-effects associated with the administration of racemic cisapride, or while achieving a higher bioavailability than achieved with racemic cisapride, and wherein the (-)-cisapride or pharmaceutically acceptable salt thereof comprises at least 90% by weight of the total amount of cisapride in the composition. |
